Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (LE3570/2-1)
Deutsche Forschungsgemeinschaft (3570/3-1)
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 23 July 2024
Revised: 22 October 2024
Accepted: 22 October 2024
First Online: 2 December 2024
Declarations
:
: LHL has served on the advisory board for Daiichi Sankyio, Senaca, Astra Zeneca and Servier, as an external expert for Astra Zeneca and received speakers’ honoraria from Novartis and MSD.
